Table 3 The prevalence of HBs antigen-positive patients sorted by their treatment method, at the end of 2018
From: 2018 annual dialysis data report of the JSDT Renal Data Registry: patients with hepatitis
Treatment method | HBs: hepatitis B surface | HBs antigen-positive | Subtotal | Unspecified | No data available | Total | HBs antigen positivity prevalence (%) |
|---|---|---|---|---|---|---|---|
Hemodialysis | 158,700 | 2382 | 161,082 | 5,127 | 28,270 | 194,479 | 1.48 |
Hemodiafiltration | 99,864 | 1213 | 101,077 | 4,023 | 16,534 | 121,634 | 1.20 |
Hemofiltration | 9 | 1 | 10 | 0 | 2 | 12 | 10.00 |
Blood adsorption dialysis | 1202 | 36 | 1238 | 37 | 159 | 1434 | 2.91 |
Home hemodialysis | 544 | 5 | 549 | 15 | 144 | 708 | 0.91 |
Peritoneal dialysis | 5857 | 85 | 5942 | 374 | 2753 | 9069 | 1.43 |
Subtotal | 266,176 | 3722 | 269,898 | 9576 | 47,862 | 327,336 | 1.38 |
Unspecified/no data available | 0 | 0 | 0 | 0 | 0 | 0 | Â |
Total | 266,176 | 3722 | 269,898 | 9576 | 47,862 | 327,336 | 1.38 |